A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).
Uta Oelschlaegel(University Hospital Carl Gustav Carus), Christian Thiede(University Hospital Carl Gustav Carus), Gerhard Ehninger(University Hospital Carl Gustav Carus), Frank Kroschinsky(University Hospital Carl Gustav Carus), Sina Koch(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Markus Schaich(Rems-Murr-Klinikum), Stefani Parmentier(Klinik und Poliklinik für Psychotherapie und Psychosomatik)
Cited by 6
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k